Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

4.15
-0.0150-0.36%
Volume:1.10M
Turnover:4.54M
Market Cap:797.18M
PE:-18.45
High:4.25
Open:4.17
Low:4.03
Close:4.16
52wk High:5.10
52wk Low:2.71
Shares:192.32M
Float Shares:126.05M
Volume Ratio:0.54
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2246
EPS(LYR):-0.3800
ROE:-45.88%
ROA:-16.46%
PB:10.30
PE(LYR):-10.91

Loading ...

Arbutus Biopharma Secures Mixed Ruling in Moderna Patent Case

TIPRANKS
·
Feb 07

Arbutus Biopharma Corp - U.S. Court Issues Memorandum in Arbutus VS. Moderna Case - SEC Filing

THOMSON REUTERS
·
Feb 07

Arbutus faces higher bar to argue infringement by Moderna, says Jefferies

TIPRANKS
·
Feb 03

Moderna reverses lower after court issues memo in patent fight with Arbutus

TIPRANKS
·
Feb 03

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:38 PM

Reuters
·
Feb 03

Nasdaq Net Change Percentage Gainers & Losers

Dow Jones
·
Jan 21

European Patent Office ruling ‘clear win’ for Moderna, says Citi

TIPRANKS
·
Jan 20

Arbutus says European patent revoked by European Patent Office

TIPRANKS
·
Jan 20

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live
·
Jan 17

Top Midday Decliners

MT Newswires Live
·
Jan 17

Arbutus Biopharma Down Over 14%, on Pace for Largest Percent Decrease Since July 2020 -- Data Talk

Dow Jones
·
Jan 17

BRIEF-Arbutus Biopharma Corp - EPO Revokes Arbutus Biopharma's European Patent EP 2279254 - SEC Filing

Reuters
·
Jan 16

Arbutus Biopharma Corp: Co Disagrees With Outcome, Plans to File Petition for Review by Enlarged Board of Appeal of Epo

THOMSON REUTERS
·
Jan 16

Arbutus Biopharma Corp - Epo Revokes Arbutus Biopharma's European Patent Ep 2279254 - SEC Filing

THOMSON REUTERS
·
Jan 16

European Patent Office Revokes Arbutus Biopharma Patent Amid Ongoing Litigation

Reuters
·
Jan 16

Trevi Therapeutics Names David Hastings CFO

MT Newswires Live
·
Dec 04, 2025

Arbutus Biopharma Q3 Revenue USD 500 Thousand

Reuters
·
Nov 20, 2025

Arbutus Biopharma Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 15, 2025

Arbutus Biopharma Q3 revenue and net loss miss analyst estimates

Reuters
·
Nov 13, 2025

Earnings Flash (ABUS) Arbutus Biopharma Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
Nov 13, 2025